Developer docs
API playgroundTry for free, no card

Search company profiles

Dosentrx

Full company profile

uuid0008jkb

Namestring
Dosentrx
Legal namestring
Dosentrx
Websiteurl
dosentrx.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Dosentrx (DBA ReX by Dosentrx) is a privately held digital health company founded in 2011 that has developed ReX, a connected medication management device and platform. ReX is an FDA-listed medical device consisting of a hardware unit paired with replaceable pill cartridges that tracks medication intake, supports scheduled and unscheduled dosing, captures patient-reported outcomes, and enables two-way communication between patients and their care teams. The platform is HIPAA compliant and tracks operational metrics including 186,000+ pills administered and 88,000+ patient-reported outcomes answered.

The company's intellectual property rests on a patent portfolio of 20+ inventions held by founder Alan Paz, who personally invented, designed, and developed the ReX platform. Dosentrx is led by CEO and Board Chairman Mark Summers, a veteran entrepreneur who previously founded ThreeWire (sold to a global clinical research services firm) and held senior executive roles at Spine-Tech and Alcon. The leadership team is rounded out by CFO and General Counsel Liron Levi-Gabay and CCO Andrew Gregoire, the latter bringing 25+ years of healthcare and pharma services experience.

Dosentrx operates a B2B2C distribution model in which ReX devices are delivered to patients at no direct cost through specialty pharmacy partners. Revenue is generated through managed-services arrangements with those pharmacy and care-team channel partners rather than direct patient billing. The company is headquartered in Plymouth, Minnesota with origins in Modi'in, Israel, serves the United States market, and operates with 11-50 employees. A single funding round from Engage Venture Partners was recorded in March 2023.

Short descriptiontext

Dosentrx (ReX) is a privately held digital health company that builds an FDA-listed, HIPAA-compliant connected medication management device. It delivers ReX to patients at no cost through specialty pharmacy partners under a B2B2C managed-services model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersModi'in, Israel
HQ citystring
Modi'in
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medication adherence, connected medical device, digital health platform, remote patient monitoring, specialty pharmacy services
Industry5 codes
1Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
CodeHLACAPAHPrimaryYes
2Therapeutic Companion Apps (Drug-Device-Digital Combination)
CodeHLACANAHPrimaryNo
3Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)
CodeHLAFALAJPrimaryNo
4Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
CodeHLALAIAGPrimaryNo
5Specialty Pharmacy & Complex Therapy Management Platforms
CodeHLACAKAGPrimaryNo
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Digital Health Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Pharmacy Partnership Model
TypeManaged Services
Description

ReX is provided to patients at no cost through specialty pharmacy partnerships. Revenue appears to be generated through B2B arrangements with specialty pharmacy partners rather than direct patient billing.

dosentrx.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Free for patients via specialty pharmacy partners
ModelOtherBilling cadenceMulti-year contract
Notes

The ReX device and service are provided to patients at no cost through specialty pharmacy partners. No direct patient billing is involved.

dosentrx.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ReX
Description

A digital health platform and FDA Class I listed medical device that helps patients manage medication and stay connected to their care teams.

dosentrx.com
Core offering1 text field

Dosentrx sells ReX, a connected medication management medical device platform that tracks pill administration through a hardware device with replaceable pill cartridges, captures patient-reported outcomes, and keeps patients in contact with their care teams. The device is distributed through specialty pharmacy partners who provide it to patients at no cost, with revenue derived from B2B arrangements with those partners. The system is HIPAA compliant and FDA listed, with documented usage of 186,000+ pills administered and 88,000+ patient-reported outcomes answered.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 186K+ pills administered through the ReX platform
+1 more record
Product overview1 text field

ReX by Dosentrx is a unified digital health platform built around a connected medication management device. The core offering consists of the ReX hardware device and its accompanying software features, including a companion system for care team connectivity, progress reporting, and patient-reported outcomes tracking. Additional components include replaceable pill cartridges and a user manual. The platform is provided to patients at no cost through specialty pharmacy partners.

Product and service1 record
1ReX connected medication management device
CategoryDigital health medical device
Description

The ReX connected medication management device is an FDA-listed, HIPAA-compliant hardware-and-software platform that tracks pill administration, schedules doses, captures patient-reported outcomes, and keeps patients in contact with their care teams. It is provided to patients at no cost through specialty pharmacy partners, with revenue derived from B2B arrangements with those partners.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Specialty Pharmacy Partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

ReX is distributed exclusively through specialty pharmacy partners who provide the device to patients at no additional cost. This partnership enables wide distribution of the connected medication management platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dosentrx

Digital Health Medical Devicesdosentrx.com

Dosentrx (ReX) is a privately held digital health company that builds an FDA-listed, HIPAA-compliant connected medication management device. It delivers ReX to patients at no cost through specialty pharmacy partners under a B2B2C managed-services model.

What Dosentrx does

Dosentrx (DBA ReX by Dosentrx) is a privately held digital health company founded in 2011 that has developed ReX, a connected medication management device and platform. ReX is an FDA-listed medical device consisting of a hardware unit paired with replaceable pill cartridges that tracks medication intake, supports scheduled and unscheduled dosing, captures patient-reported outcomes, and enables two-way communication between patients and their care teams. The platform is HIPAA compliant and tracks operational metrics including 186,000+ pills administered and 88,000+ patient-reported outcomes answered.

The company's intellectual property rests on a patent portfolio of 20+ inventions held by founder Alan Paz, who personally invented, designed, and developed the ReX platform. Dosentrx is led by CEO and Board Chairman Mark Summers, a veteran entrepreneur who previously founded ThreeWire (sold to a global clinical research services firm) and held senior executive roles at Spine-Tech and Alcon. The leadership team is rounded out by CFO and General Counsel Liron Levi-Gabay and CCO Andrew Gregoire, the latter bringing 25+ years of healthcare and pharma services experience.

Dosentrx operates a B2B2C distribution model in which ReX devices are delivered to patients at no direct cost through specialty pharmacy partners. Revenue is generated through managed-services arrangements with those pharmacy and care-team channel partners rather than direct patient billing. The company is headquartered in Plymouth, Minnesota with origins in Modi'in, Israel, serves the United States market, and operates with 11-50 employees. A single funding round from Engage Venture Partners was recorded in March 2023.

Dosentrx firmographics

Firmographics
Name
Dosentrx
Legal name
Dosentrx
Website
https://dosentrx.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Dosentrx (ReX) is a privately held digital health company that builds an FDA-listed, HIPAA-compliant connected medication management device. It delivers ReX to patients at no cost through specialty pharmacy partners under a B2B2C managed-services model.
Ownership category
akta.pro rank

Dosentrx industry classification

Industry
Product category
Digital Health Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro primary industry
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
akta.pro secondary industries
Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH), Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

  • Medication adherence
  • Connected medical device
  • Digital health platform
  • Remote patient monitoring
  • Specialty pharmacy services

Where Dosentrx is headquartered

Location

Headquarters

HQ city
Modi'in
HQ country
Israel
HQ region
Middle East

Offices1 record

Markets served

Dosentrx business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Specialty Pharmacy Partnership Model: ReX is provided to patients at no cost through specialty pharmacy partnerships. Revenue appears to be generated through B2B arrangements with specialty pharmacy partners rather than direct patient billing.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractFree for patients via specialty pharmacy partners

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Dosentrx product offering

Product offering

Core offering

Dosentrx sells ReX, a connected medication management medical device platform that tracks pill administration through a hardware device with replaceable pill cartridges, captures patient-reported outcomes, and keeps patients in contact with their care teams. The device is distributed through specialty pharmacy partners who provide it to patients at no cost, with revenue derived from B2B arrangements with those partners. The system is HIPAA compliant and FDA listed, with documented usage of 186,000+ pills administered and 88,000+ patient-reported outcomes answered.

Product overview

ReX by Dosentrx is a unified digital health platform built around a connected medication management device. The core offering consists of the ReX hardware device and its accompanying software features, including a companion system for care team connectivity, progress reporting, and patient-reported outcomes tracking. Additional components include replaceable pill cartridges and a user manual. The platform is provided to patients at no cost through specialty pharmacy partners.

Differentiator

Problem solved

Functional benefit

Brands

  • ReX: A digital health platform and FDA Class I listed medical device that helps patients manage medication and stay connected to their care teams.

Products and services

  • ReX connected medication management device The ReX connected medication management device is an FDA-listed, HIPAA-compliant hardware-and-software platform that tracks pill administration, schedules doses, captures patient-reported outcomes, and keeps patients in contact with their care teams. It is provided to patients at no cost through specialty pharmacy partners, with revenue derived from B2B arrangements with those partners.

Quantifiable outcome

  • 186K+ pills administered through the ReX platform
  • +1 more outcomes

Companies that use Dosentrx

Customer profile

Segments2 records

Ideal customer profiles2 records

Dosentrx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Dosentrx partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Specialty Pharmacy PartnerscoreChannel Partner/ Reseller/ DistributorReX is distributed exclusively through specialty pharmacy partners who provide the device to patients at no additional cost. This partnership enables wide distribution of the connected medication management platform.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Dosentrx competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Dosentrx social profiles

Digital presence

Dosentrx compliance and trust

Trust signal

Compliance2 records

Dosentrx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dosentrx leadership team

Management profile

Number of profiles

Profiles4 records

Dosentrx funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dosentrx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dosentrx

What does Dosentrx do?

Dosentrx sells ReX, a connected medication management medical device platform that tracks pill administration through a hardware device with replaceable pill cartridges, captures patient-reported outcomes, and keeps patients in contact with their care teams. The device is distributed through specialty pharmacy partners who provide it to patients at no cost, with revenue derived from B2B arrangements with those partners. The system is HIPAA compliant and FDA listed, with documented usage of 186,000+ pills administered and 88,000+ patient-reported outcomes answered.

Is Dosentrx a public or private company?

Dosentrx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dosentrx founded?

Dosentrx was founded in 2011. It employs 11 to 50 people.

Where is Dosentrx based?

Dosentrx is headquartered in Modi'in, Israel, in the Middle East region.

How does Dosentrx make money?

One revenue line is on record: specialty Pharmacy Partnership Model.

Does Dosentrx have an API?

No public API is recorded for Dosentrx.

What industry is Dosentrx in?

Dosentrx's product category is Digital Health Medical Devices. Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers), with a secondary code of HLACANAH, Therapeutic Companion Apps (Drug-Device-Digital Combination). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals